Literature DB >> 11437281

Tet-system for the regulation of gene expression during embryonic development.

L M Fedorov1, O Y Tyrsin, V Krenn, E V Chernigovskaya, U R Rapp.   

Abstract

The ability to control gene expression in a temporal and spatial manner provides a new tool for the study of mammalian gene function particularly during development and oncogenesis. In this study the suitability of the tet-system for investigating embryogenesis was tested in detail. The tTACMV(M1) and rTACMV-3 (reverse Tc-controlled transactivator) transgenic mice were bred with NZL-2 bi-reporter mice containing the vector with a tTA/rTA responsive bidirectional promoter that allows simultaneous regulation of expression of two reporter genes encoding luciferase and beta-galactosidase. In both cases reporter genes were found to be expressed in a wide spectrum of tissues of double transgenic embryos and adult mice. The earliest expression was detected in tTACMV(M1)/NZL-2 embryos at embryonic day 10.5 (E10.5) and rTACMV-3/NZL-2 embryos at E13.5. Doxycycline abolished beta-gal expression in tTACMV(M1)/NZL-2 but induced it in rTACMV-3/NZL-2 embryos including late stages of embryo-genesis. The tTA and rtTA transactivators thus revealed a partially complementary mode of action during second half of embryonic development. These experiments demonstrated that both Tet regulatory systems function during embryonic development. We conclude that the Tet systems allows regulation of gene expression during embryonic development and that 'double reporter' animals like the NZL-2 mice are useful tools for the characterization of newly generated tet transactivator lines expressing tTA (or rtTA) in embryonic as well as in adult tissues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11437281     DOI: 10.1023/a:1016632110931

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  25 in total

1.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  A comparison of the germline potential of differently aged ES cell lines and their transfected descendants.

Authors:  L M Fedorov; H Haegel-Kronenberger; J Hirchenhain
Journal:  Transgenic Res       Date:  1997-05       Impact factor: 2.788

Review 3.  Antibiotic use in pregnancy.

Authors:  J S Dashe; L C Gilstrap
Journal:  Obstet Gynecol Clin North Am       Date:  1997-09       Impact factor: 2.844

4.  Use of tetracycline-controlled gene expression systems to study mammalian cell cycle.

Authors:  S Freundlieb; U Baron; A L Bonin; M Gossen; H Bujard
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

5.  Inducible gene knockouts in the small intestinal and colonic epithelium.

Authors:  J R Saam; J I Gordon
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

6.  Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.

Authors:  A Kistner; M Gossen; F Zimmermann; J Jerecic; C Ullmer; H Lübbert; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Doxycycline control of prion protein transgene expression modulates prion disease in mice.

Authors:  P Tremblay; Z Meiner; M Galou; C Heinrich; C Petromilli; T Lisse; J Cayetano; M Torchia; W Mobley; H Bujard; S J DeArmond; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

8.  Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.

Authors:  P A Furth; L St Onge; H Böger; P Gruss; M Gossen; A Kistner; H Bujard; L Hennighausen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

9.  Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene.

Authors:  S Efrat; D Fusco-DeMane; H Lemberg; O al Emran; X Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

10.  Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection.

Authors:  M Koedood; A Fichtel; P Meier; P J Mitchell
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

View more
  8 in total

1.  Placental anomalies and fetal loss in mice, after administration of doxycycline in food for tet-system activation.

Authors:  René Moutier; Françoise Tchang; Stéphane M Caucheteux; Colette Kanellopoulos-Langevin
Journal:  Transgenic Res       Date:  2003-06       Impact factor: 2.788

2.  Development of an immortalised, post-pubertal gonadotrophin-releasing hormone neuronal cell line.

Authors:  A Wolfe; Y Ng; S A Divall; S P Singh; S Radovick
Journal:  J Neuroendocrinol       Date:  2008-07-09       Impact factor: 3.627

3.  HIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation.

Authors:  Yun Kyung Hahn; Elizabeth M Podhaizer; Kurt F Hauser; Pamela E Knapp
Journal:  Glia       Date:  2012-08-02       Impact factor: 7.452

4.  RHEB1 expression in embryonic and postnatal mouse.

Authors:  Qi Tian; James L Smart; Joachim H Clement; Yingming Wang; Alex Derkatch; Harald Schubert; Michael V Danilchik; Daniel L Marks; Lev M Fedorov
Journal:  Histochem Cell Biol       Date:  2015-12-26       Impact factor: 4.304

5.  Airway-specific inducible transgene expression using aerosolized doxycycline.

Authors:  Purushothama Rao Tata; Ana Pardo-Saganta; Mythili Prabhu; Vladimir Vinarsky; Brandon M Law; Benjamin A Fontaine; Andrew M Tager; Jayaraj Rajagopal
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

6.  Tetracycline-inducible system for regulation of skeletal muscle-specific gene expression in transgenic mice.

Authors:  Mischala A Grill; Mark A Bales; Amber N Fought; Kristopher C Rosburg; Stephanie J Munger; Parker B Antin
Journal:  Transgenic Res       Date:  2003-02       Impact factor: 2.788

7.  Conditional gene expression in the mouse using a Sleeping Beauty gene-trap transposon.

Authors:  Aron M Geurts; Andrew Wilber; Corey M Carlson; Paul D Lobitz; Karl J Clark; Perry B Hackett; R Scott McIvor; David A Largaespada
Journal:  BMC Biotechnol       Date:  2006-06-26       Impact factor: 2.563

8.  Conditional over-expression of estrogen receptor alpha in a transgenic mouse model.

Authors:  Kathleen S Hruska; Maddalena T Tilli; Shuxun Ren; Ion Cotarla; Theresa Kwong; Minglin Li; Joseph D Fondell; Judy A Hewitt; Robert D Koos; Priscilla A Furth; Jodi A Flaws
Journal:  Transgenic Res       Date:  2002-08       Impact factor: 3.145

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.